article thumbnail

What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers

FDA Law Blog

This meeting will host a panel of rare disease patients, caregivers, and advocates to have a focused discussion on the emerging field of gene therapy (regulated at the FDA by OTP). At least some (if not all) of the panelists will have had experience participating in gene therapy trials.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

Furthermore, CRISPR/Cas9 presents a promising avenue for overcoming genetic diseases in the near future. Cell and Gene Therapies Cell and gene therapies (C&GT) remain at the forefront of healthcare innovation, representing one of the fastest-growing therapeutic areas. billion in 2021, is projected to reach $42.56